Benjamin Kelmendi
Medical Director · Yale-New Haven Hospital
Credentials: · ·
History
Research
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial
JAMA · 2023 · 408 citations
Systematic review or meta-analysis · Molecular Psychiatry · 2006 · 393 citations
Overview of glutamatergic neurotransmission in the nervous system
Review · Pharmacology · 2012 · 246 citations
- CP
32 papers · 7 as a resident
14 papers
13 papers
- TA
12 papers
10 papers
9 papers · 1 as a resident
- MB
9 papers · 7 as a resident
- JH
7 papers · 4 as a fellow
Grants
- 2021–2025
The Neural Correlates of the Effects of Psilocybin in OCD: Randomized Controlled Study
National Institute of Mental Health · K23
Contact PI · $757.8K · Yale University
Clinical trials
- 2024–2027
Open-Label Psilocybin Study in Transdiagnostic Population
Principal investigator · Recruiting · Phase 1
Yale University
- 2024–2028
The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD.
Principal investigator · Withdrawn · Phase 1
Yale University
- 2023–2027
Effects of Repeated Psilocybin Dosing in OCD
Principal investigator · Active not recruiting · Phase 1
Yale University
- 2018–2024
Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
Principal investigator · Completed · Phase 1
Yale University